Biblio

Author [ Title(Desc)] Type Year
Filters: First Letter Of Title is S  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
S
(2014). (S039) ALDH-Expressing Cancer Stem Cells Are Associated With Inferior Survival in Patients With Resected Pancreatic Adenocarcinoma Treated With Adjuvant Chemoradiation.Oncology (Williston Park)28.
Cheng, P., Eksioglu, E.A., Chen, X., Kandell, W., Le Trinh, T., Cen, L., Qi, J., Sallman, D.A., Zhang, Y., Tu, N., et al. (2019). S100A9-induced overexpression of PD-1/PD-L1 contributes to ineffective hematopoiesis in myelodysplastic syndromes.Leukemia.
Yang, T., Cheng, J., You, J., Yan, B., Liu, H., and Li, F. (2018). S100B promotes chemoresistance in ovarian cancer stem cells by regulating p53.Oncol Rep.
Romani, R., Manni, G., Donati, C., Pirisinu, I., Bernacchioni, C., Gargaro, M., Pirro, M., Calvitti, M., Manni, G., Bagaglia, F., et al. (2018). S1P promotes migration, differentiation and immune regulatory activity in amniotic-fluid-derived stem cells.Eur J Pharmacol.
Dillmann, C., Mora, J., Olesch, C., Brüne, B., and Weigert, A. (2015). S1PR4 is required for plasmacytoid dendritic cell differentiation.Biol Chem.
Lee, J.Eun, Lim, M.Sun, Park, J.Hyun, Park, C.Hwan, and Koh, H.Chul (2015). S6K Promotes Dopaminergic Neuronal Differentiation Through PI3K/Akt/mTOR-Dependent Signaling Pathways in Human Neural Stem Cells.Mol Neurobiol.
Ghosh, J., Kobayashi, M., Ramdas, B., Chatterjee, A., Ma, P., Mali, R.Singh, Carlesso, N., Liu, Y., Plas, D.R., Chan, R.J., et al. (2016). S6K1 regulates hematopoietic stem cell self-renewal and leukemia maintenance.J Clin Invest.
Juan, A.H., and Sartorelli, V. (2016). S6K1ing to ResTOR Adipogenesis with Polycomb.Mol Cell62, 325-326.
Matelska, D., Purta, E., Panek, S., Boniecki, M.J., Bujnicki, J.M., and Dunin-Horkawicz, S. (2013). S6:S18 ribosomal protein complex interacts with a structural motif present in its own mRNA.Rna.
Li, J.-Y., Xiao, T., Yi, H.-M., Yi, H., Feng, J., Zhu, J.-F., Huang, W., Lu, S.-S., Zhou, Y.-H., Li, X.-H., et al. (2018). S897 phosphorylation of EphA2 is indispensable for EphA2-dependent nasopharyngeal carcinoma cell invasion, metastasis and stem properties.Cancer Lett.
Pontier-Bres, R., Rampal, P., Peyron, J.-F., Munro, P., Lemichez, E., and Czerucka, D. (2015). The Saccharomyces boulardii CNCM I-745 Strain Shows Protective Effects against the B. anthracis LT Toxin.Toxins (Basel)7, 4455-4467.
Strekalova, E., Malin, D., Weisenhorn, E.M.M., Russell, J.D., Hoelper, D., Jain, A., Coon, J.J., Lewis, P.W., and Cryns, V.L. (2019). S-adenosylmethionine biosynthesis is a targetable metabolic vulnerability of cancer stem cells.Breast Cancer Res Treat.
Torre, A., Vertu-Ciolino, D., Mazoyer, C., Selva, J., Lornage, J., and Salle, B. (2016). Safeguarding Fertility With Whole Ovary Cryopreservation and Microvascular Transplantation: Higher Follicular Survival With Vitrification Than With Slow Freezing in a Ewe Model.Transplantation.
Dejosez, M., Ura, H., Brandt, V.L., and Zwaka, T.P. (2013). Safeguards for Cell Cooperation in Mouse Embryogenesis Shown by Genome-Wide Cheater Screen.Science.
Aiuti, A., and Naldini, L. (2016). Safer conditioning for blood stem cell transplants.Nat Biotechnol34, 721-723.
Mariottini, A., Innocenti, C., Forci, B., Magnani, E., Mechi, C., Barilaro, A., Nistri, R., Fani, A., Saccardi, R., Massacesi, L., et al. (2018). Safety and efficacy of autologous hematopoietic stem cell transplantation following natalizumab discontinuation in aggressive Multiple Sclerosis.Eur J Neurol.
Raut, S.S., Shah, S.A., Sharanangat, V.V., Shah, K.M., Patel, K.A., Anand, A.S., Talati, S.S., Panchal, H.P., Patel, A.A., Parikh, S.K., et al. (2015). Safety and Efficacy of Eltrombopag in Post-hematopoietic Stem Cell Transplantation (HSCT) Thrombocytopenia.Indian J Hematol Blood Transfus31, 413-415.
Pardanani, A., Harrison, C., Cortes, J.E., Cervantes, F., Mesa, R.A., Milligan, D., Masszi, T., Mishchenko, E., Jourdan, E., Vannucchi, A.M., et al. (2015). Safety and Efficacy of Fedratinib in Patients With Primary or Secondary Myelofibrosis: A Randomized Clinical Trial.Jama Oncol.
Bassi, S., Stroppa, E.M., Moroni, C.F., Arbasi, M.C., Trabacchi, E., Di Franco, A., Lazzaro, A., Bernuzzi, P., Moretto, M., Arcari, A., et al. (2015). Safety and efficacy of granulocyte colony-stimulating factor biosimilars in engraftment after autologous stem cell transplantation for haematological malignancies: a 4-year, single institute experience with different conditioning regimens.Blood Transfus1-6.
Leow, S.N., Luu, C.D., Nizam, M.H.Hairul, Mok, P.L., Ruhaslizan, R., Wong, H.S., Halim, W.Haslina Wa, Ng, M.H., Ruszymah, B.H.I., Chowdhury, S.R., et al. (2015). Safety and Efficacy of Human Wharton's Jelly-Derived Mesenchymal Stem Cells Therapy for Retinal Degeneration.Plos One10, e0128973.
Neofytos, D., Huang, Y.-T., Cheng, K., Cohen, N., Perales, M.-A., Barker, J., Giralt, S., Jakubowski, A., and Papanicolaou, G. (2015). Safety and Efficacy of Intermittent Intravenous Administration of High-Dose Micafungin.Clin Infect Dis61, S652-S661.
Li, X., Hu, Y.-D., Guo, Y., Chen, Y., Guo, D.-X., Zhou, H.-L., Zhang, F.-L., and Zhao, Q.-N. (2014). Safety and Efficacy of Intracoronary Human Umbilical Cord-Derived Mesenchymal Stem Cell Treatment for Very Old Patients with Coronary Chronic Total Occlusion.Curr Pharm Des.
Ai, H., Fu, Y.W., Wang, Y.Q., Jiao, X.L., Wei, X.D., and Song, Y.P. (2018). [Safety and efficacy of ruxolitinib as a salvage regimen for patients with refractory acute and chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation].Zhonghua Xue Ye Xue Za Zhi39, 1026-1029.
Eder, S., Labopin, M., Finke, J., Bunjes, D., Olivieri, A., Santarone, S., Rambaldi, A., Kanz, L., Messina, G., Mohty, M., et al. (2016). Safety and efficacy of thiotepa-based conditioning for allogeneic transplantation in AML: a survey from the ALWP of the EBMT.Bone Marrow Transplant.
Lin, M., Yuan, Y., Xu, J., Cai, X., Liu, S., Niu, L., Chen, J., Li, Q., and Xu, K. (2015). Safety and efficacy study of nasopharyngeal cancer stem cell vaccine.Immunol Lett.

Pages